mynth
10/2024100%

Data-AL acquired by Carasent

GERMANY Software / Industry-Specific Software / Healthcare EV €0–15M

Context

Carasent ASA has completed the acquisition of Data-Al GmbH, a German EHR software provider, marking Carasent's entry into the German private clinic market. The transaction was announced in a regulatory press release on 28 October 2024 and follows a year‑long evaluation process that identified Data-Al as a suitable partner for market expansion. Data-Al continues to operate under its existing brand while integrating into Carasent's broader portfolio. The acquisition aligns with Carasent's strategy to broaden its geographic reach and augment its product suite with a proven German‑market solution. By adding Data-Al's platforms, Carasent gains immediate access to a customer base of over 1,000 clinics and inherits a team with extensive local regulatory expertise. The move supports Carasent's objective to accelerate the rollout of its Webdoc X solution across Germany, leveraging cross‑selling opportunities and shared technology components. Operationally, Carasent plans to retain Data-Al's development and support staff to ensure continuity for existing clients while harmonising back‑office functions such as finance and human resources. The combined entity is expected to benefit from economies of scale in cloud hosting, joint marketing initiatives, and unified product roadmaps, which should enhance service consistency and reduce operational redundancies across the expanded market footprint.

Data-AL, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of 15x–25x.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Data-Al GmbH is a German provider of electronic health record (EHR) software serving private healthcare clinics. Founded in 1988, the company developed two core platforms, Data-Al and Data-Cur, which enable patient data capture, appointment scheduling, billing integration, and regulatory reporting. Its client base comprises more than 1,000 small to medium sized private clinics distributed across most German federal states, each operating under a subscription model that generates recurring revenue. The firm employs a local team of thirty professionals who manage product development, implementation, and support, ensuring compliance with German data protection and medical standards. Product architecture relies on modular, cloud‑based components that can be configured to match clinic size and specialty, while maintaining a single‑sign‑on interface for clinicians. Data-Al’s business model emphasizes long‑term contracts with low churn, providing a stable cash flow that supports incremental feature upgrades and integration with third‑party diagnostic tools. The company’s market position is reinforced by a reputation for deep understanding of local regulatory requirements and a support network that offers on‑site training and 24/7 help‑desk assistance. Revenue is derived primarily from software licences, maintenance fees, and optional consulting services, with a secondary income stream from data analytics add‑ons.

Ent. Value

€0–15M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2023
€0–5M
€0–5M
[members only]
2022
€0–5M
€0–5M
[members only]

Other operations with Carasent

Other operations with Carasent
DateAcquirerTargetCountrySector
02/2026CARASENTINFOSOLUTIONS SVERIGESWEDENHealthcare

Similar deals in Software

Similar deals in Software
DateAcquirerTargetCountrySector
11/2024SOGELINKNETISYSFRANCEIndustry-Specific Software
11/2024CREDIT MUTUEL EQUITYTOPSOLIDFRANCEEngineering & Design Software
10/2024SESA GROUPSMART ENGINEERINGGERMANYEngineering & Design Software
10/2024SAGARDFUTUR MASTERFRANCESupply Chain & Ops
10/2024VERTISEITVISUAL ART SWEDENSWEDENMarTech
10/2024BONNIER CAPITALVERTISEITSWEDENMarTech
10/2024TOMRAC-TRACEGERMANYIndustry-Specific Software
10/2024VAISALANEVIS TECHNOLOGYUNITED KINGDOMIndustry-Specific Software
10/2024GROUPE LACOURDRAGON2000UNITED KINGDOMAutomotive
10/2024CAPZAJVS GROUPFRANCEIndustry-Specific Software

REFERENCES

Valuation range: EV €0–15M

Revenue range: €0–5M

EBITDA range: €0–5M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Data-AL by Carasent are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: data-al

FAQ

What transaction does this page cover?

This page covers Carasent’s acquisition of 100% of Data-AL, a German company specialised in Industry-Specific Software, in 2024.

How was the acquisition of Data-AL by Carasent valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €0–15M band, its EV/EBITDA multiple within the 15x - 25x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Data-AL’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Data-AL generated annual revenue estimated in the €0–5M range and EBITDA in the €0–5M bracket (FY 2023). Detailed financial figures are available to members.

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.